TrialClinical drug investigation2021

Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Jocelyn Y Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.